About this trial
The aim of this clinical trial is to determine if cerebello-spinal direct current stimulation (csDCS) is effective in treating gait disorders in individuals with chronic stroke. Additionally, the trial seeks to evaluate the safety of this technique.
The primary objectives include:
Investigating whether cerebello-spinal direct current stimulation improves gait and functional mobility in participants with chronic stroke.
Assessing any potential side effects associated with the method.
Researchers will conduct a comparative analysis between cerebello-spinal direct current stimulation and a sham procedure (which mimics the stimulation without any actual effect) to assess its effectiveness in addressing gait disorders and enhancing mobility.
Participants in the trial will:
Undergo cerebello-spinal direct current stimulation combined with treadmill training or a sham procedure with treadmill training daily over a two-week period.
Eligibility criteria
Qualifiers
Confirmation of Stroke by digital or physical imaging or medical report
Gait impairment
Stroke with at least 6 months after ictus
Disqualifiers
Metallic implants in spinal cord
Major orthopedic/rheumatological disorders
Inability of verbal or non-verbal communication
Trial design
Treatments tested in this trial
- Cerebello-spinal direct current stimulation
- Sham Comparator
Treatment groups
Sponsors and collaborators
Universidade Federal de Pernambuco
Lead sponsor
Universidade Federal do Rio de Janeiro
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Collaborator